A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation

A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation

The scarcity of age-appropriate pharmaceutical formulations is one of the major challenges impeding successful management of tuberculosis (TB) prevalence in minors. To this end, we designed and assessed the quality of a multiparticulate reconstitutable suspension powder containing fixed dose rifampi...

Full description

Bibliographic Details
Main Authors: Penelope N. Rampedi, Modupe O. Ogunrombi, James Wesley-Smith, Oluwatoyin A. Adeleke
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
tuberculosis
paediatric
antitubercular
pharmaceutical formulations
dosage form
multiparticulate drug carrier
Online Access:https://www.mdpi.com/1999-4923/15/1/64

Internet

https://www.mdpi.com/1999-4923/15/1/64

Similar Items